Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDX vs GSK✓SelectedUSD · GSKGDX vs GSK performance historyLatest closeAs of-3.77%11/19
Stock and ETF performance explorer

GDX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+129.2%
GSK return
+39.6%
Excess return
+89.6%
Maximum drawdown
-46.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.8%-1.6%-2.2%-3.3%
7D-12.0%-4.7%-7.3%-10.9%
30D-16.4%-4.7%-11.7%-15.3%
3M-26.0%-8.8%-17.3%-24.3%
6M-14.1%-4.6%-9.4%-13.2%
YTD-16.1%+1.0%-17.0%-16.6%
1Y-5.1%+6.9%-11.9%-7.1%
3Y+162.3%+52.5%+109.8%+122.2%
5Y+129.2%+40.3%+88.9%+87.8%
All+129.2%+39.6%+89.6%+87.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling